nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in Gaucher disease: Therapeutic goals and evaluation and monitoring guidelines
|
Weinreb, Neal J. |
|
2004 |
|
S5 |
p. A1- 1 p. |
artikel |
2 |
Advances in Gaucher disease: Therapeutic goals and evaluation and monitoring guidelines
|
Weinreb, Neal J. |
|
2004 |
|
S5 |
p. A2- 1 p. |
artikel |
3 |
Antithrombotic therapy in acute coronary syndromes: Key notes from ESSENCE and TIMI 11B
|
Fox, Keith A.A |
|
2001 |
|
S5 |
p. 67-74 8 p. |
artikel |
4 |
Assessment of treatment strategy in high-risk surgical patients
|
Samama, M.M |
|
2000 |
|
S5 |
p. 10-14 5 p. |
artikel |
5 |
A targeted approach to thrombosis: New data, new perspectives—Introduction
|
Davidson, Bruce L |
|
2001 |
|
S5 |
p. 1-3 3 p. |
artikel |
6 |
Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial
|
Cohen, Alexander T |
|
2001 |
|
S5 |
p. 31-38 8 p. |
artikel |
7 |
Clinical and economic aspects of managing venous thromboembolism in the outpatient setting
|
Agnelli, Giancarlo |
|
2001 |
|
S5 |
p. 58-66 9 p. |
artikel |
8 |
Conclusion
|
Davidson, Bruce L |
|
2001 |
|
S5 |
p. 75-77 3 p. |
artikel |
9 |
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
|
Arnold, Donald M. |
|
2007 |
|
S5 |
p. S12-S23 12 p. |
artikel |
10 |
Developing a novel antithrombotic in the academic environment
|
Hirsh, Jack |
|
2001 |
|
S5 |
p. 4-11 8 p. |
artikel |
11 |
Disclaimer
|
|
|
2006 |
|
S5 |
p. A2- 1 p. |
artikel |
12 |
Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease
|
Caprini, Joseph A |
|
2001 |
|
S5 |
p. 12-19 8 p. |
artikel |
13 |
Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients
|
Weinreb, Neal J. |
|
2004 |
|
S5 |
p. 15-22 8 p. |
artikel |
14 |
Immune-Mediated Thrombocytopenias: Focus on Chronic Immune Thrombocytopenic Purpura
|
McMillan, Robert |
|
2007 |
|
S5 |
p. S1-S2 2 p. |
artikel |
15 |
Introduction
|
Weinreb, Neal J. |
|
2004 |
|
S5 |
p. 1-3 3 p. |
artikel |
16 |
Looking forward in the treatment of deep-vein thrombosis
|
Turpie, Alexander G.G |
|
2001 |
|
S5 |
p. 49-57 9 p. |
artikel |
17 |
Management of thromboembolism in the outpatient setting
|
Agnelli, G |
|
2000 |
|
S5 |
p. 23-26 4 p. |
artikel |
18 |
Masthead
|
|
|
2006 |
|
S5 |
p. CO2- 1 p. |
artikel |
19 |
Masthead
|
|
|
2007 |
|
S5 |
p. IFC- 1 p. |
artikel |
20 |
New frontiers in deep vein thrombosis management: Conclusions
|
ten Cate, J.W |
|
2000 |
|
S5 |
p. 27-28 2 p. |
artikel |
21 |
New frontiers in deep vein thrombosis management: Introduction
|
ten Cate, J.W |
|
2000 |
|
S5 |
p. 1-2 2 p. |
artikel |
22 |
New therapeutic options in deep vein thrombosis prophylaxis
|
Eriksson, B.I |
|
2000 |
|
S5 |
p. 7-9 3 p. |
artikel |
23 |
Other Immune Thrombocytopenias
|
Liebman, Howard |
|
2007 |
|
S5 |
p. S24-S34 11 p. |
artikel |
24 |
Question and Answer
|
|
|
2006 |
|
S5 |
p. S18-S19 2 p. |
artikel |
25 |
Recent Advances in the Treatment of Childhood Immune Thrombocytopenic Purpura
|
Tarantino, Michael |
|
2006 |
|
S5 |
p. S11-S17 7 p. |
artikel |
26 |
Review of Therapies for Immune Thrombocytopenic Purpura
|
Bussel, James |
|
2006 |
|
S5 |
p. S1-S2 2 p. |
artikel |
27 |
Risk assessment of venous thromboembolism in medical patients
|
Harenberg, J |
|
2000 |
|
S5 |
p. 3-6 4 p. |
artikel |
28 |
Supplement Disclaimer
|
|
|
2007 |
|
S5 |
p. A2- 1 p. |
artikel |
29 |
Suppl masthead
|
Young, Neal S. |
|
2004 |
|
S5 |
p. C2- 1 p. |
artikel |
30 |
Table of Contents
|
|
|
2006 |
|
S5 |
p. A1- 1 p. |
artikel |
31 |
Table of Contents
|
|
|
2007 |
|
S5 |
p. A1- 1 p. |
artikel |
32 |
The Pathogenesis of Chronic Immune Thrombocytopenic Purpura
|
McMillan, Robert |
|
2007 |
|
S5 |
p. S3-S11 9 p. |
artikel |
33 |
The potential role of new therapies in deep-vein thrombosis prophylaxis
|
Wille-Jørgensen, Peer |
|
2001 |
|
S5 |
p. 20-30 11 p. |
artikel |
34 |
Therapeutic goals in the treatment of Gaucher disease
|
Pastores, Gregory M. |
|
2004 |
|
S5 |
p. 4-14 11 p. |
artikel |
35 |
Thrombopoietin Mimetic Agents in the Management of Immune Thrombocytopenic Purpura
|
Newland, Adrian |
|
2007 |
|
S5 |
p. S35-S45 11 p. |
artikel |
36 |
Thromboprophylaxis in neurosurgical patients
|
Nurmohamed, M.T |
|
2000 |
|
S5 |
p. 15-18 4 p. |
artikel |
37 |
Treatment of Immune Thrombocytopenic Purpura in Adults
|
Bussel, James |
|
2006 |
|
S5 |
p. S3-S10 8 p. |
artikel |
38 |
Unexplored territories in the nonsurgical patient: A look at pregnancy
|
Eldor, Amiram |
|
2001 |
|
S5 |
p. 39-48 10 p. |
artikel |
39 |
Venous thromboembolic disease management of the nonsurgical moderate- and high-risk patient
|
Cohen, A.T |
|
2000 |
|
S5 |
p. 19-22 4 p. |
artikel |